Revvity, Inc.

Informe acción NYSE:RVTY

Capitalización de mercado: US$12.9b

Salud financiera de hoja de balance de Revvity

Salud financiera controles de criterios 4/6

Revvity tiene un patrimonio de accionistas total de $7.9B y una deuda total de $3.9B, lo que sitúa su ratio deuda-patrimonio en 49.5%. Sus activos y pasivos totales son $13.6B y $5.7B respectivamente. El BAIT de Revvity es de $381.5M, por lo que su ratio de cobertura de intereses es de 14.3. Tiene efectivo e inversiones a corto plazo que ascienden a $1.6B.

Información clave

49.4%

Ratio deuda-patrimonio

US$3.88b

Deuda

Ratio de cobertura de intereses26.5x
EfectivoUS$1.70b
PatrimonioUS$7.85b
Total pasivoUS$5.59b
Activos totalesUS$13.43b

Actualizaciones recientes sobre salud financiera

Recent updates

Why We're Not Concerned About Revvity, Inc.'s (NYSE:RVTY) Share Price

Apr 03
Why We're Not Concerned About Revvity, Inc.'s (NYSE:RVTY) Share Price

Revvity: Enter Now As Reorganization Takes Shape

Mar 21

We Think Revvity (NYSE:RVTY) Can Stay On Top Of Its Debt

Feb 28
We Think Revvity (NYSE:RVTY) Can Stay On Top Of Its Debt

Investors Can Find Comfort In Revvity's (NYSE:RVTY) Earnings Quality

Feb 13
Investors Can Find Comfort In Revvity's (NYSE:RVTY) Earnings Quality

Should You Think About Buying Revvity, Inc. (NYSE:RVTY) Now?

Jan 19
Should You Think About Buying Revvity, Inc. (NYSE:RVTY) Now?

An Intrinsic Calculation For Revvity, Inc. (NYSE:RVTY) Suggests It's 49% Undervalued

Jan 04
An Intrinsic Calculation For Revvity, Inc. (NYSE:RVTY) Suggests It's 49% Undervalued

Revvity: More Than A Name Change Is Needed For PerkinElmer

Dec 29

Why We're Not Concerned About Revvity, Inc.'s (NYSE:RVTY) Share Price

Dec 20
Why We're Not Concerned About Revvity, Inc.'s (NYSE:RVTY) Share Price

Is Revvity (NYSE:RVTY) Using Too Much Debt?

Oct 07
Is Revvity (NYSE:RVTY) Using Too Much Debt?

Revvity: Recent Investments, Acquisitions, Not Pulling Economic Weight (Rating Downgrade)

Oct 04

At US$108, Is Revvity, Inc. (NYSE:RVTY) Worth Looking At Closely?

Sep 22
At US$108, Is Revvity, Inc. (NYSE:RVTY) Worth Looking At Closely?

An Intrinsic Calculation For Revvity, Inc. (NYSE:RVTY) Suggests It's 40% Undervalued

Aug 17
An Intrinsic Calculation For Revvity, Inc. (NYSE:RVTY) Suggests It's 40% Undervalued

Revvity: New Name - But New Investment Outlook? Reiterate Buy

Jul 18

Revvity (NYSE:RVTY) Seems To Use Debt Quite Sensibly

Jul 03
Revvity (NYSE:RVTY) Seems To Use Debt Quite Sensibly

What Does Revvity, Inc.'s (NYSE:RVTY) Share Price Indicate?

Jun 17
What Does Revvity, Inc.'s (NYSE:RVTY) Share Price Indicate?

Calculating The Fair Value Of Revvity, Inc. (NYSE:PKI)

May 16
Calculating The Fair Value Of Revvity, Inc. (NYSE:PKI)

We Think PerkinElmer (NYSE:PKI) Can Stay On Top Of Its Debt

Mar 28
We Think PerkinElmer (NYSE:PKI) Can Stay On Top Of Its Debt

When Should You Buy PerkinElmer, Inc. (NYSE:PKI)?

Mar 13
When Should You Buy PerkinElmer, Inc. (NYSE:PKI)?

PerkinElmer Q4 2022 Earnings Preview

Feb 13

A Look At The Intrinsic Value Of PerkinElmer, Inc. (NYSE:PKI)

Feb 10
A Look At The Intrinsic Value Of PerkinElmer, Inc. (NYSE:PKI)

PerkinElmer: Capital Budgeting A Key Factor To The Investment Debate

Jan 31

Danaher earnings weigh on other life sciences tools, services companies

Jan 24

PerkinElmer says Q4 results will meet or exceed prior guidance

Jan 09

PerkinElmer (NYSE:PKI) Has A Pretty Healthy Balance Sheet

Dec 27
PerkinElmer (NYSE:PKI) Has A Pretty Healthy Balance Sheet

Is It Time To Consider Buying PerkinElmer, Inc. (NYSE:PKI)?

Dec 12
Is It Time To Consider Buying PerkinElmer, Inc. (NYSE:PKI)?

PerkinElmer receives FDA approval for EONIS assay for spinal muscular atrophy in newborns

Nov 14

PerkinElmer reports mixed Q3 earnings, initiates Q4 and updates FY22 pro forma guidance

Nov 08

PerkinElmer, Inc.'s (NYSE:PKI) Intrinsic Value Is Potentially 48% Above Its Share Price

Oct 28
PerkinElmer, Inc.'s (NYSE:PKI) Intrinsic Value Is Potentially 48% Above Its Share Price

PerkinElmer declares $0.07 dividend

Oct 27

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($3.0B) de RVTY superan a sus pasivos a corto plazo ($1.5B).

Pasivo a largo plazo: Los activos a corto plazo ($3.0B) de RVTY no cubren sus pasivos a largo plazo ($4.2B).


Historial y análisis de deuda-patrimonio

Nivel de deuda: El ratio deuda neta-patrimonio (29.2%) de RVTY se considera satisfactorio.

Reducción de la deuda: El ratio deuda-patrimonio de RVTY ha pasado de 71.8% a 49.5% en los últimos 5 años.

Cobertura de la deuda: La deuda de RVTY no está bien cubierta por el flujo de caja operativo (2.3%).

Cobertura de intereses: Los pagos de intereses de la deuda de RVTY están bien cubiertos por el BAIT (14.3x cobertura).


Hoja de balance


Descubre empresas con salud financiera